Financial Ratios

CAMSON BIO TECHNOLOGIES LTD.

NSE : NABSE : 538858ISIN CODE : INE845E01012Industry : AgricultureHouse : Private
BSE3.310 (0 %)
PREV CLOSE ( ) 3.31
OPEN PRICE ( ) 3.31
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1760
TODAY'S LOW / HIGH ( )3.31 3.31
52 WK LOW / HIGH ( ) 3.313.31
NSE
This Company is not listed in NSE
Select year
ParticularsMar2019Mar2018Mar2017Mar2016Mar2015
Operational & Financial Ratios
   Earnings Per Share (Rs)-7.30-3.74-7.68-12.611.03
   CEPS(Rs)-4.97-1.34-5.20-5.375.50
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)14.9222.2225.6834.7588.00
   Tax Rate(%)-2.770.000.735.2458.35
Margin Ratios
   Core EBITDA Margin(%)-329.380.18-127.65-56.6010.94
   EBIT Margin(%)-405.20-30.34-161.51-137.546.78
   Pre Tax Margin(%)-428.17-58.09-224.39-157.184.37
   PAT Margin (%)-440.02-58.09-222.74-148.941.82
   Cash Profit Margin (%)-299.89-20.85-150.85-63.449.73
Performance Ratios
   ROA(%)-16.76-7.84-14.56-15.301.02
   ROE(%)-39.31-15.61-25.44-20.551.32
   ROCE(%)-19.21-4.92-12.18-15.454.05
   Asset Turnover(x)0.040.130.070.100.56
   Sales/Fixed Asset(x)0.030.130.070.161.16
   Working Capital/Sales(x)-0.17-1.19-0.24-0.881.33
Efficiency Ratios
   Fixed Capital/Sales(x)29.947.6914.466.260.86
   Receivable days428.5583.44358.161164.42247.28
   Inventory Days2429.07494.00373.03248.3970.37
   Payable days191.24374.321059.65649.8251.77
Valuation Parameters
   PER(x)0.000.000.000.0091.10
   PCE(x)-1.39-11.32-3.34-6.5317.03
   Price/Book(x)0.460.680.681.011.06
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)14.174.889.465.991.87
   EV/Core EBITDA(x)-5.3570.77-10.55-11.5112.72
   EV/EBIT(x)-3.50-16.09-5.86-4.3627.55
   EV/CE(x)0.580.670.670.890.98
   M Cap / Sales4.172.365.044.151.66
Growth Ratio
   Net Sales Growth(%)-74.2386.57-59.26-85.0016.31
   Core EBITDA Growth(%)-1090.48114.3629.84-153.12-1.29
   EBIT Growth(%)-244.1864.9652.15-404.16-30.54
   PAT Growth(%)-95.2051.3439.07-1327.48-76.77
   EPS Growth(%)-95.2051.3439.07-1327.48-80.47
Financial Stability Ratios
   Total Debt/Equity(x)1.110.730.600.450.14
   Current Ratio(x)0.550.740.290.483.58
   Quick Ratio(x)0.140.100.090.313.07
   Interest Cover(x)-17.64-1.09-2.57-7.002.81
   Total Debt/Mcap(x)2.401.070.880.450.13

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.